Company Analysis CVS Health Corporation
1. Summary
Advantages
- Dividends (4.41%) are higher than the sector average (1.28%).
- The stock's return over the last year (13.03%) is higher than the sector average (-18.79%).
- Current debt level 32.75% is below 100% and has decreased over 5 years from 40.01%.
- The company's current efficiency (ROE=6.07%) is higher than the sector average (ROE=-83.32%)
Disadvantages
- Price (66.35 $) is higher than fair price (38.96 $)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| CVS Health Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | 5.2% | -14.1% | -0.4% |
| 90 days | -5.5% | -18% | 6% |
| 1 year | 13% | -18.8% | 9.2% |
CVS vs Sector: CVS Health Corporation has outperformed the "Healthcare" sector by 31.82% over the past year.
CVS vs Market: CVS Health Corporation has outperformed the market by 3.81% over the past year.
Stable price: CVS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CVS with weekly volatility of 0.2506% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (66.35 $) is higher than the fair price (38.96 $).
Price is higher than fair: The current price (66.35 $) is 41.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (12.02) is lower than that of the sector as a whole (52.65).
P/E vs Market: The company's P/E (12.02) is lower than that of the market as a whole (61.83).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.7322) is lower than that of the sector as a whole (10.86).
P/BV vs Market: The company's P/BV (0.7322) is lower than that of the market as a whole (20.82).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.1487) is lower than that of the sector as a whole (4.03).
P/S vs Market: The company's P/S indicator (0.1487) is lower than that of the market as a whole (16).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (9.49) is lower than that of the sector as a whole (16.78).
EV/Ebitda vs Market: The company's EV/Ebitda (9.49) is lower than that of the market as a whole (27.04).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -7.15% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-7.15%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (6.07%) is higher than that of the sector as a whole (-83.32%).
ROE vs Market: The company's ROE (6.07%) is lower than that of the market as a whole (43%).
5.5. ROA
ROA vs Sector: The company's ROA (1.83%) is lower than that of the sector as a whole (6.43%).
ROA vs Market: The company's ROA (1.83%) is lower than that of the market as a whole (23.28%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (6.52%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (6.52%) is lower than that of the market as a whole (9.2%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.41% is higher than the average for the sector '1.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.41% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 4.41% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (73.1%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
